Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Commodities

Gold’s Battle for the $4,000 Milestone Intensifies

Robert Sasse by Robert Sasse
November 5, 2025
in Commodities, Forex, Gold & Precious Metals, Market Commentary
0
VanEck Merk Gold Trust Stock
0
SHARES
9
VIEWS
Share on FacebookShare on Twitter

The gold market is currently navigating a period of significant volatility. Having reached a fresh all-time high in October, the precious metal now faces headwinds from a more assertive Federal Reserve and a strengthening U.S. dollar. Despite this recent pullback, the fundamental case for gold remains strong, setting the stage for a continued struggle to breach the critical $4,000 per ounce level.

Fundamental Backdrop Retains Strength

Even with the current phase of weakness, gold’s status as a safe-haven asset is supported by several powerful drivers. The World Bank continues to project elevated precious metal prices through 2026, fueled by persistent investment demand and ongoing geopolitical friction. The robust performance of the VanEck Merk Gold Trust (OUNZ), which has gained over 50% since the start of the year, underscores the metal’s sustained appeal. Three core factors underpin this positive outlook:

  • Sustained Central Bank Purchases: Institutional buying activity remains vigorous.
  • Macroeconomic Uncertainties: Inflationary pressures and geopolitical risks show no signs of abating.
  • Physical Demand: Investors continue to seek refuge in tangible assets.

Fed’s Hawkish Stance Applies Pressure

The primary catalyst for gold’s recent correction is clear: the U.S. central bank has tempered market expectations for additional interest rate cuts this year. Following the late October policy meeting, Chairman Jerome Powell signaled that the recent 25-basis-point reduction might be the final one for 2025. This unexpected shift propelled the U.S. dollar higher, placing downward pressure on gold, its traditional rival. On November 4th, the price fell by 1.7% to $3,934.77 per ounce, before staging a minor recovery to $3,941.92 by Wednesday.

Should investors sell immediately? Or is it worth buying VanEck Merk Gold Trust?

The Physical Gold Advantage

A key differentiator for the VanEck Merk Gold Trust is its unique physical redemption feature. Investors have the option to exchange their shares for actual gold bars, which are held in secure London vaults. This physical delivery mechanism sets it apart from competing funds like the SPDR Gold Shares (GLD) or the iShares Gold Trust (IAU). The fund’s assets are composed entirely of physical gold bars, each with a minimum purity of 99.5%. These holdings are subject to regular audits and are stored in high-security facilities.

The question now is whether gold can extend its impressive yearly gains and successfully reclaim the $4,000 threshold. The answer will largely depend on the future trajectory of Federal Reserve policy and the evolution of global uncertainties.

Ad

VanEck Merk Gold Trust Stock: Buy or Sell?! New VanEck Merk Gold Trust Analysis from February 7 delivers the answer:

The latest VanEck Merk Gold Trust figures speak for themselves: Urgent action needed for VanEck Merk Gold Trust investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

VanEck Merk Gold Trust: Buy or sell? Read more here...

Tags: VanEck Merk Gold Trust
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Schnitzer Steel Industries Stock
Analysis

Navigating Change: Schnitzer Steel’s Digital and Structural Evolution

February 6, 2026
Lynas Stock
Asian Markets

Leadership Transition Looms for Key Rare Earths Producer

February 6, 2026
Luxor Industrialration Stock
Commodities

Industrial Timber Sector Eyes a Path to Stability

February 6, 2026
Next Post
DigitalOcean Holdings Stock

DigitalOcean's Pivotal Earnings Report: AI Strategy Under the Microscope

US Foods Stock

US Foods Faces Critical Earnings Test Amid Divided Investor Sentiment

Roblox Registered (A) Stock

Platform Power vs. Engine Excellence: A Tale of Two Tech Titans

Recommended

C3.ai Stock

Is C3.ai Stock Poised for a Rebound?

2 months ago
MMM stock news

Clarification on Hyperlink and Promotional Fees

2 years ago

XOMA Corporation Expands Portfolio with Acquisition of DSUVIA

2 years ago
Microsoft Stock

A Bold Bet: Peter Thiel’s Hedge Fund Doubles Down on Microsoft

1 month ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

ServiceNow Shares Face Market Skepticism Despite Record Performance

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

A New Chapter for First Busey as CrossFirst Merger Finalizes

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Trending

Avanos Medical Stock
Analysis

Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth

by SiterGedge
February 7, 2026
0

Avanos Medical is navigating a critical strategic transformation. The medical device firm is streamlining its operations to...

Guaranty Bancshares Stock

Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion

February 7, 2026
Yirendai Stock

Yirendai Charts a New Course with Tech-Driven Strategy

February 7, 2026
ServiceNow Stock

ServiceNow Shares Face Market Skepticism Despite Record Performance

February 7, 2026
Orthofix Medical Stock

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth
  • Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion
  • Yirendai Charts a New Course with Tech-Driven Strategy

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com